Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 1/20 | 0.62 |
| ▸ | HTR2B | P41595 | 1/20 | 0.62 |
| ▸ | SCN3A | Q9NY46 | 3/20 | 0.52 |
| ▸ | SCN9A | Q15858 | 2/20 | 0.52 |
| ▸ | ULK1 | O75385 | 1/20 | 0.50 |
| ▸ | PSMB8 | P28062 | 2/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.48 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.48 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.48 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | MITF | O75030 | 1/20 | 0.45 |
| ▸ | KLF5 | Q13887 | 1/20 | 0.45 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31148173 | 0.91 | HTR2C (0.59) | HTR2CHTR2BSCN3ASCN9AULK1 | |
| SCHEMBL31148175 | 0.91 | HTR2C (0.59) | HTR2CHTR2BSCN3ASCN9AULK1 | |
| SCHEMBL31148199 | 0.91 | HTR2C (0.59) | HTR2CHTR2BSCN3ASCN9AULK1 | |
| SCHEMBL30714994 | 0.90 | HTR2C (0.58) | HTR2CHTR2BSCN3ASCN9AULK1 | |
| Hydrochloric Acid SCHEMBL31148076 | 0.89 | HTR2C (0.57) | HTR2CHTR2BSCN3ASCN9AULK1 | |
| Hydrochloric Acid SCHEMBL31148178 | 0.89 | HTR2C (0.56) | HTR2CHTR2BSCN3ASCN9AULK1 | |
| Hydrochloric Acid SCHEMBL31148098 | 0.88 | HTR2C (0.55) | HTR2CHTR2BSCN3ASCN9AULK1 | |
| SCHEMBL10281534 | 0.86 | SCN3A (0.54) | HTR2CHTR2BSCN3ASCN9AULK1 | |
| SCHEMBL10299187 | 0.82 | SCN3A (0.50) | SCN3ASCN9APSMB8HDAC8SCN5A | |
| Trifluoroacetic Acid SCHEMBL31148191 | 0.81 | HTR2C (0.49) | HTR2CHTR2BSCN3ASCN9AULK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9394279-B2 | Anti-viral compounds | ABBVIE INC. (US) | 2016-07-19 | — | — | US | disclosed |
| US-20120172290-A1 | Anti-Viral Compounds | ABBOTT LABORATORIES (US) | 2012-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120172290-A1 | Anti-Viral Compounds | HAVCR2, EIF2AK2, MAVS | HTR2C 4364/4885HTR2B 4676/4885SCN3A 4568/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.